These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8630994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR, Billings PC, Wan XS, Newberne PM.
    Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698
    [Abstract] [Full Text] [Related]

  • 3. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 6. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
    Song J, Medline A, Mason JB, Gallinger S, Kim YI.
    Cancer Res; 2000 Oct 01; 60(19):5434-40. PubMed ID: 11034085
    [Abstract] [Full Text] [Related]

  • 7. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW, Donahue JJ, Wan XS.
    Nutr Cancer; 1996 Oct 01; 26(2):209-17. PubMed ID: 8875558
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, Lubet RA.
    Cancer Res; 2000 Apr 01; 60(7):1864-70. PubMed ID: 10766173
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 01; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Dec 01; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 17. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.
    Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, Dove WF.
    Cancer Res; 1996 Feb 15; 56(4):710-4. PubMed ID: 8631000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.